AHA Coding Clinic® for HCPCS - 2016 Quarter 1; For Your Information
Deletions and changes for several HCPCS/CPT codes for drugs, biologicals, and radiopharmaceuticals
As of January 1, 2016, several HCPCS C-codes for certain drugs, biologicals, and radiopharmaceuticals were deleted and replaced by permanent HCPCS codes. For many other HCPCS/CPT codes for drugs, biologicals, and radiopharmaceuticals changes were made to their code descriptors. A crosswalk of the deleted HCPCS C-codes and their replacements are listed in the table as well. CY 2015 HCPCS/ CPT code CY 2015 Long Descriptor CY 2016 HCPCS/ CPT code CY 2016 Long Descriptor C9025 Injection, ramucirumab, 5 mg J9308 Injection, ramucirumab, 5 mg C9026 Injection, vedolizumab, 1 mg J3380 Injection, vedolizumab, 1 mg C9027 Injection, pembrolizumab, 1 mg...
Subscribe or sign in to view the full article.
Article Overview
This page reviews a set of HCPCS and CPT code changes effective in 2016 for drugs, biologicals, radiopharmaceuticals, and related products. It is useful for coders, billers, and reimbursement staff who need to understand which identifiers were retired, which permanent codes replaced them, and which descriptors were revised. The article presents a crosswalk-style table and focuses on update categories rather than in-depth clinical guidance.
Why This Topic Matters
Annual code updates can affect claim reporting, charge capture, and internal reference tables. Reviewing these changes helps coding teams keep drug and biologic billing materials aligned with the current code set.
Article Sections
-
HCPCS/CPT crosswalk table for 2016 updates
A crosswalk of selected drug, biological, and radiopharmaceutical codes showing deleted identifiers, replacement identifiers, and updated descriptors. The section presents the principal 2016 revision categories in tabular form.
-
Descriptor changes for selected HCPCS/CPT codes
A set of entries where existing identifiers retained or changed their wording in the code descriptor. The section covers multiple product types and update patterns.
What You Will Learn
- Which categories of drug and biologic coding updates were included for 2016
- How crosswalk tables can be used to review retired and replacement HCPCS/CPT identifiers
- What kinds of HCPCS/CPT descriptor revisions were highlighted in the article
- Which product groups were affected by the update set
Who Should Read This
- Medical coders
- Hospital and physician practice billers
- Revenue cycle staff
- Compliance teams
- Coding educators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com